sc 58125 has been researched along with osu 03012 in 1 studies
| Studies (sc 58125) | Trials (sc 58125) | Recent Studies (post-2010) (sc 58125) | Studies (osu 03012) | Trials (osu 03012) | Recent Studies (post-2010) (osu 03012) |
|---|---|---|---|---|---|
| 93 | 0 | 15 | 85 | 0 | 55 |
| Protein | Taxonomy | sc 58125 (IC50) | osu 03012 (IC50) |
|---|---|---|---|
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bushnell, TP; Friedman, AE; Phipps, RP; Rahman, I; Ryan, EP | 1 |
1 other study(ies) available for sc 58125 and osu 03012
| Article | Year |
|---|---|
Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells.
Topics: Animals; B-Lymphocytes; Catalytic Domain; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Glutamate-Cysteine Ligase; Glutathione; Humans; Isoxazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Mice; Mice, Knockout; Oxidative Stress; Pyrazoles; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Sulfones | 2008 |